(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EXPRESSION THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

EXPRESSION THERAPEUTICS

ST13

US500000077304501

Class

42

Filing

77304501

Registration

3649311

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

02/05/2019

Trademark type

Combined

Nice classes

42

Filing date

10/15/2007

Registration date

07/07/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/05/2019

Last transaction

02/05/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

11/21/2005

First use in commerce

10/01/2006

Drawing code

3

Owner type

16

Owner location

Tucker, GA

Examiner

BENMAMAN, ALICE

Law office

M70

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the words "Expression Therapeutics" wherein the "SS" in "Expression" comprises a DNA strand with the letters "AT" "CG" "GC" "TA" inside.

Holders and representatives

Holders

Expression Therapeutics, LLC

Representatives

Expression Therapeutics, LLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research servicesresearchdevelopment of new products of others for use in the diagnosis and treatment of individuals with hemophilia A

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/05/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/05/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/05/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/05/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/08/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

01/08/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/07/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/21/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/06/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/06/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/06/2015

E815

TEAS SECTION 8 & 15 RECEIVED

02/23/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/23/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/22/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/04/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/04/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

07/07/2009

PUBO

PUBLISHED FOR OPPOSITION

04/21/2009

NPUB

NOTICE OF PUBLICATION

04/01/2009

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

02/06/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/24/2009

ALIE

ASSIGNED TO LIE

01/24/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/12/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/17/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/16/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/16/2008

CNRT

NON-FINAL ACTION MAILED

08/12/2008

CNRT

NON-FINAL ACTION WRITTEN

08/11/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/18/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/18/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/18/2008

CNRT

NON-FINAL ACTION MAILED

01/24/2008

CNRT

NON-FINAL ACTION WRITTEN

01/24/2008

DOCK

ASSIGNED TO EXAMINER

01/24/2008

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

10/19/2007

NWAP

NEW APPLICATION ENTERED

10/18/2007

Continuous trademark protection

Get notified about every new filing that threatens EXPRESSION THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.